re: Ann: 2009 Financial Results - Preliminary... i agreei see no future in ozl.not going no where.its a shame doh , i had plenty going for it.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%